SHPH Nilai Wutuh Bisnis Shuttle Pharmaceuticals Inc

Tandha merek Shuttle Pharmaceuticals (SHPH)

Shuttle Pharmaceuticals (SHPH) is developing radiosensitizers to enhance radiation therapy, funding its research through investments. The stock's price history reflects an Enterprise Value of 24.15. Successful integration of the drug into global oncology protocols will ensure scalability with low distribution costs. Currently, the biotech firm is focusing on early-stage testing, relying exclusively on partnerships with scientific communities without mergers.

SHPH Shuttle Pharma: Nilai Perusahaan ing interval 23.11.2025 - 27.10.2026

SHPH (Shuttle Pharmaceuticals): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:
Bagan owah-owahan rega Shuttle Pharmaceuticals Holdings, Inc.|SHPH - Bagan rega target
- data kapitalisasi pasar:
Biji pasar Shuttle Pharmaceuticals|SHPH - Nilai Perusahaan
- data kapitalisasi buku:
Nilai Akuntansi Saham Shuttle Pharmaceuticals|SHPH - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih shuttlepharma.com|SHPH - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Shuttle Pharmaceuticals|SHPH - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal shuttlepharma.com|SHPH - Gunggung utang perusahaan|Utang marang nilai buku Shuttle Pharmaceuticals
Pambiji fundamental perusahaan:SHPH (Shuttle Pharmaceuticals Holdings, Inc.)
Produk sing diprodhuksi Shuttle Pharmaceuticals Holdings, Inc.

This metric reflects operational efficiency through the sum of market capitalization and net debt, determining the actual cost of a full business buyout. For Shuttle Pharmaceuticals (SHPH), whose valuation depends on the success of brain cancer drug trials, the enterprise value serves as an indicator of the developer's financial stability during the intervals between clinical phases.

Pesaing langsung

CNS Pharmaceuticals Inc - Nilai Dipunlarasaken Utang lan Kas